Berlin, Germany

Bertram Wiedenmann


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bertram Wiedenmann: Innovator in Optical Diagnostics

Introduction

Bertram Wiedenmann is a notable inventor based in Berlin, Germany, known for his contributions to the field of optical diagnostics. With two patents to his name, he has made significant advances in the development of peptide-dye conjugates used as contrast agents. His innovative work has the potential to enhance diagnostic techniques in medical imaging.

Latest Patents

Wiedenmann's latest patents focus on the creation of short-warp peptide-dye conjugates that function as contrast agents for optical diagnostics. The first patent details the incorporation of cyanine dyes and vaso-active intestinal peptide analogs, offering a novel approach to peptide-dye conjugate development. The second patent centers on short-chain peptide-dye conjugates that are specially designed for tumor diagnosis. These compounds, derived from vaso-active intestinal peptide, somatostatin, or neurotensin, serve as effective optical diagnostic agents.

Career Highlights

Throughout his career, Bertram Wiedenmann has worked with reputable organizations such as the Institute for Diagnostic Research and the Institut für Diagnostikforschung GmbH. His efforts in these institutions have propelled the research and application of optical diagnostic agents, showcasing his commitment to improving healthcare diagnostics.

Collaborations

Wiedenmann has collaborated with esteemed colleagues such as Kai Licha and Andreas Becker. Their partnerships have fostered an environment of innovation and knowledge sharing, further advancing the field of optical diagnostics and enhancing the potential for groundbreaking medical solutions.

Conclusion

Bertram Wiedenmann stands out as a prominent inventor in the realm of optical diagnostics. His patents indicate a commitment to enhancing medical imaging practices through the innovative use of peptide-dye conjugates. As the field continues to evolve, Wiedenmann's contributions are likely to play a crucial role in shaping future diagnostic technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…